MedTrace Logo

Low Glycemic Index Diets vs. High Cereal Fibre Diets in Type 2 Diabetes

NCT00438698 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2015-12-16

No results posted yet for this study

Summary

Large observational studies have shown cereal fiber to protect from diabetes and heart disease. Despite the success of acarbose, an α-glucosidase hydrolase inhibitor, which lowers the glycemic index of foods containing starch, sucrose and maltodextrins, the use of diets containing low glycemic index foods still remains to be established. We will therefore provide otherwise healthy individuals with type 2 diabetes intensive counseling on food selection either to improve glucose control using high cereal fiber dietary strategies or low glycemic index foods. Studies will last 6 months with bloods taken for HbA1c, glucose and blood lipids. If the study shows a benefit for either or both diets then use of high fiber and/or low glycemic index foods in the diet may provide another potential way to improve glucose control and lower cholesterol levels in non-insulin dependent diabetes.

Conditions

Interventions

OTHER

Low Glycemic Index diet

Diet to emphasize carbohydrate foods low in glycemic index

OTHER

High Cereal Fibre Diets

Diet to emphasize whole wheat carbohydrate cgoices

Sponsors & Collaborators

  • University of Toronto

    lead OTHER

Principal Investigators

  • David JA Jenkins, MD, PhD · University of Toronto, St. Michael's Hospital

  • Cyril WC Kendall, PhD · University of Toronto, St. Michael's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00438698 on ClinicalTrials.gov